Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Mother Child ; 24(3): 32-36, 2021 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-33930262

RESUMEN

The Mediator complex subunit 13-like is a part of the large Mediator complex. Recently, a large number of patients were diagnosed with mutations in this gene, which makes it one of the most frequent causes of syndromic intellectual disability. In this work, we report a patient with a novel de novo likely pathogenic variant c.5941C>T, p.(Gln1981*) in the MED13L gene with severe intellectual disability and facial dysmorphism. Uncommon findings like lack of speech, strabismus and self-destructive behaviour present in our patient allowed us to further define the phenotypic spectrum of mental retardation and distinctive facial features with or without cardiac defects syndrome.


Asunto(s)
Anomalías Múltiples/diagnóstico , Anomalías Múltiples/genética , Anomalías Múltiples/fisiopatología , Haploinsuficiencia , Discapacidad Intelectual/genética , Mutación con Pérdida de Función , Complejo Mediador/genética , Niño , Variación Genética , Humanos , Discapacidad Intelectual/diagnóstico , Discapacidad Intelectual/fisiopatología , Masculino , Mutación , Fenotipo
2.
Transplant Proc ; 52(9): 2844-2848, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32684371

RESUMEN

Juvenile xanthogranuloma (JXG) is a rare histiocytic disorder classified as non-Langerhans cell histiocytosis; although it is usually a benign and self-limiting disease, it can be fatal in some cases, especially with systemic dissemination. We present a case report of a boy with therapy-resistant disseminated JXG who was treated with systemic chemotherapy and received 3 allogeneic hematopoietic stem cell transplantations (allo-HSCTs) from an unrelated donor. The post-transplant period was complicated by acute graft vs host disease and lymphoproliferative disease caused by Epstein-Barr virus. Currently, almost 7.5 years after the first transplantation, the boy is in complete remission with full donor chimerism and without symptoms of JXG. The presented data confirm rare observations that allo-HSCT can lead to durable remission of systemic JXG, which warrants its use in life-threatening, therapy-resistant subtypes of disease.


Asunto(s)
Busulfano/análogos & derivados , Terapia Combinada/métodos , Trasplante de Células Madre Hematopoyéticas/métodos , Terapia Recuperativa/métodos , Xantogranuloma Juvenil/terapia , Antineoplásicos Alquilantes/uso terapéutico , Busulfano/uso terapéutico , Preescolar , Humanos , Masculino , Inducción de Remisión , Xantogranuloma Juvenil/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA